Free Trial
CVE:PTF

Pender Growth Fund (PTF) Stock Price, News & Analysis

Pender Growth Fund logo
C$9.90 +0.05 (+0.51%)
As of 04/16/2025

About Pender Growth Fund Stock (CVE:PTF)

Key Stats

Today's Range
C$9.89
C$9.90
50-Day Range
C$9.37
C$10.50
52-Week Range
C$6.90
C$11.38
Volume
3,850 shs
Average Volume
2,757 shs
Market Capitalization
C$71.78 million
P/E Ratio
1.60
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Pender Growth Fund Inc. specializes in later stage, special situations, and restructuring investments. The fund also provides expansion capital and invests in small caps and Eligible Small Businesses ("ESBs"). It seeks to invest in illiquid public and private companies in information technology, communications, life sciences, and proprietary technologies sectors and undervalued technology companies. The fund targets companies based in British Columbia, Canada. It typically invests over Cdn $500,000 ($0.51) or invests between Cdn $1.5 million ($1.53 million) and Cdn $3 million ($3.06 million) in each portfolio company with revenues between Cdn $5 million ($5.10 million) and Cdn $15 million ($15.30 million). The fund prefers to invest in undervalued public companies.

Receive PTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pender Growth Fund and its competitors with MarketBeat's FREE daily newsletter.

PTF Stock News Headlines

The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
See More Headlines

PTF Stock Analysis - Frequently Asked Questions

Pender Growth Fund's stock was trading at C$11.19 at the beginning of the year. Since then, PTF shares have decreased by 11.5% and is now trading at C$9.90.
View the best growth stocks for 2025 here
.

Shares of PTF stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pender Growth Fund investors own include Armata Pharmaceuticals (ARMP), BioCardia (BCDA), Bristol-Myers Squibb (BMY), Range Cancer Therapeutics ETF (CNCR), Inovio Pharmaceuticals (INO), Insight Select Income Fund (INSI) and Protalix BioTherapeutics (PLX).

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Asset Management
Sub-Industry
N/A
Current Symbol
CVE:PTF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
1.60
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$44.92 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$49.38 million
Cash Flow
C$1.19 per share
Price / Cash Flow
8.35
Book Value
C$15.08 per share
Price / Book
0.66

Miscellaneous

Free Float
N/A
Market Cap
C$71.78 million
Optionable
Not Optionable
Beta
0.56
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (CVE:PTF) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners